These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24790198)

  • 1. Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's disease.
    Sharott A; Gulberti A; Zittel S; Tudor Jones AA; Fickel U; Münchau A; Köppen JA; Gerloff C; Westphal M; Buhmann C; Hamel W; Engel AK; Moll CK
    J Neurosci; 2014 Apr; 34(18):6273-85. PubMed ID: 24790198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease.
    Zaidel A; Spivak A; Grieb B; Bergman H; Israel Z
    Brain; 2010 Jul; 133(Pt 7):2007-21. PubMed ID: 20534648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal firing patterns in the subthalamic nucleus in patients with akinetic-rigid-type Parkinson's disease.
    Guo S; Zhuang P; Zheng Z; Zhang Y; Li J; Li Y
    J Clin Neurosci; 2012 Oct; 19(10):1404-7. PubMed ID: 22898200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease Patients.
    Holt AB; Kormann E; Gulberti A; Pötter-Nerger M; McNamara CG; Cagnan H; Baaske MK; Little S; Köppen JA; Buhmann C; Westphal M; Gerloff C; Engel AK; Brown P; Hamel W; Moll CKE; Sharott A
    J Neurosci; 2019 Feb; 39(6):1119-1134. PubMed ID: 30552179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency oscillations in Parkinson's disease: spatial distribution and clinical relevance.
    Wang J; Hirschmann J; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Mov Disord; 2014 Sep; 29(10):1265-72. PubMed ID: 25041924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease.
    Yang AI; Vanegas N; Lungu C; Zaghloul KA
    J Neurosci; 2014 Sep; 34(38):12816-27. PubMed ID: 25232117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency oscillations in the subthalamic nucleus: a neurophysiological marker of the motor state in Parkinson's disease.
    Özkurt TE; Butz M; Homburger M; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Exp Neurol; 2011 Jun; 229(2):324-31. PubMed ID: 21376039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression.
    Remple MS; Bradenham CH; Kao CC; Charles PD; Neimat JS; Konrad PE
    Mov Disord; 2011 Aug; 26(9):1657-62. PubMed ID: 21542021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane and Parkinson's Disease: Subthalamic Nucleus Neuronal Activity and Clinical Outcome of Deep Brain Stimulation.
    Tsai ST; Tseng GF; Kuo CC; Chen TY; Chen SY
    Anesthesiology; 2020 May; 132(5):1034-1044. PubMed ID: 32044799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease.
    van Wijk BC; Beudel M; Jha A; Oswal A; Foltynie T; Hariz MI; Limousin P; Zrinzo L; Aziz TZ; Green AL; Brown P; Litvak V
    Clin Neurophysiol; 2016 Apr; 127(4):2010-9. PubMed ID: 26971483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.
    Sharott A; Gulberti A; Hamel W; Köppen JA; Münchau A; Buhmann C; Pötter-Nerger M; Westphal M; Gerloff C; Moll CKE; Engel AK
    Neurobiol Dis; 2018 Apr; 112():49-62. PubMed ID: 29307661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinsonian Beta Dynamics during Rest and Movement in the Dorsal Pallidum and Subthalamic Nucleus.
    Eisinger RS; Cagle JN; Opri E; Alcantara J; Cernera S; Foote KD; Okun MS; Gunduz A
    J Neurosci; 2020 Apr; 40(14):2859-2867. PubMed ID: 32107277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.
    López-Azcárate J; Tainta M; Rodríguez-Oroz MC; Valencia M; González R; Guridi J; Iriarte J; Obeso JA; Artieda J; Alegre M
    J Neurosci; 2010 May; 30(19):6667-77. PubMed ID: 20463229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.